THE CONFLICT AND CONSENT WITH THE POWER IN THE POLITICAL DISCOURSE OF THE NAIVE AUTHOR

Por N. B. Lebedeva
Publicado em 2015-11-01

The Use of Levosimendan for the Treatment of Heart Failure and its Potential Organoprotective Effects

Por N. B. Lebedeva, L. Yu. Chesnokova
Publicado em 2022-05-01

Implantable cardioverter-defibrillators in sudden cardiac death prevention: guidelines and clinical practice (literature review)

Por I. V. Talibullin, N. B. Lebedeva
Publicado em 2022-04-01

PSYCHOSOCIAL FACTORS DETERMINING PROGNOSIS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION

Por N. B. Lebedeva, O. L. Barbarash
Publicado em 2003-08-01

Effect of levosimendan on long-term prognosis in patients with myocardial infarction and concomitant chronic brain ischemia

Por N. B. Lebedeva, L. Yu. Chesnokova, O. L. Barbarash
Publicado em 2021-02-01

Psychosocial features of myocardial infarction patients and rehabilitation programs’ effectiveness

Por N. B. Lebedeva, O. V. Lebedev, N. I. Tarasov, E. Yu. Yakusheva, O. L. Barbarash
Publicado em 2005-12-01

Pro-inflammatory cytokines and depression in myocardial infarction

Por O. L. Barbarash, N. B. Lebedeva, V. N. Karetnikova, S. A. Berns, V. V. Kashtalap, L. S. Barbarash
Publicado em 2011-04-01

NEW OPPORTUNITIES FOR PREVENTIVE THERAPY WITH STATINS DURING CHD PATIENTS’ REHABILITATION, WITH CLINICAL SIGNS OF MODERATE CHF: EFFECTIVENESS OF ROSUVASTATIN AND EZETIMIBE

Por N. I. Tarasov, M. N. Sinkova, L. K. Isakov, N. B. Lebedeva, V. A. Shilov, A. T. Teplyakov
Publicado em 2016-06-01

Gender-specific features of psychosocial status and their clinical effects in myocardial infarction patients

Por N. B. Lebedeva, O. V. Lebedev, E. V. Shaf, A. V. Osokina, E. Yu. Yakusheva, O. L. Barbarash
Publicado em 2007-02-01